Authors: Sato, K Tomioka, H Akaki, T Kawahara, S

Citation: K. Sato et al., Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicatingwithin Mono Mac 6 human macrophage and A-549 type II alveolar cell lines, INT J ANT A, 16(1), 2000, pp. 25-29

Authors: Tomioka, H Sato, K Kajitani, H Akaki, T Shishido, S

Citation: H. Tomioka et al., Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciproffoxacin against Mycobacterium tuberculosis and mycobacterium avium complex, ANTIM AG CH, 44(2), 2000, pp. 283-286

Authors: Akaki, T Tomioka, H Shimizu, T Dekio, S Sato, K

Citation: T. Akaki et al., Comparative roles of free fatty acids with reactive nitrogen intermediatesand reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis, CLIN EXP IM, 121(2), 2000, pp. 302-310

Authors: Shimizu, T Tomioka, H Sato, K Sano, C Akaki, T Dekio, S Yamada, Y Kamei, T Shibata, H Higashi, N

Citation: T. Shimizu et al., Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice, ANTIM AG CH, 43(3), 1999, pp. 514-519

Authors: Tomioka, H Sato, K Akaki, T Kajitani, H Kawahara, S Sakatani, M

Citation: H. Tomioka et al., Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex, ANTIM AG CH, 43(12), 1999, pp. 3001-3004